• Sanofi Acquires Tidal Therapeutics contractpharma
    April 13, 2021
    ​Sanofi acquired Tidal Therapeutics, a preclinical stage biotech company with a novel mRNA-platform for reprogramming of immune cells, for $160 million upfront and up to $310 million in milestones.
PharmaSources Customer Service